News blog: what’s the difference between Oxford and Cambridge?
John Morgan looks at the differences between Cambridge and Oxford on the £9,000 tuition cap – and the idea of ‘going private’

John Morgan looks at the differences between Cambridge and Oxford on the £9,000 tuition cap – and the idea of ‘going private’

Housing crisis in Oxford, Cambridge and London means the cost of loan and joint equity schemes has tripled in past five years

Performance targets to boost league table position are questioned as analysis shows little change in Russell Group REF order

David Matthews reports from Canada on the Trudeau government’s plans to convert academic research into commercial gains

With the latest data showing that just 17 professors in the UK are black women, two explain how a new award will help more ethnic minority staff thrive
The EU calls them TMRs, cross-border postdoctoral centres that it funds to the tune of Pounds 42,000 each. But, asks Judy Redfearn, how are they faring? About 2,000 European postdoctoral researchers...

From Lehman Brothers to La Leche League via disaster capitalism and 'the new retirement': new academic books worth adding to your reading list

Study finds that, while senior academics tend to have the most followers on social networking site, the most junior researchers are not far behind

Stereotypes, prejudice and laddish behaviour still deter young women interested in physics, engineering and computer science, says Eileen Pollack

Can a research powerhouse retain access to EU funds after a referendum backing restrictions on free movement? John Morgan reports
Brussels, 19 Feb 2004 A survey by The Scientist has found that access to publications and journals is considered the most important attribute of a university by postdoctorate researchers. The journal...
Brussels, 19 Feb 2004 A survey by The Scientist has found that access to publications and journals is considered the most important attribute of a university by postdoctorate researchers. The journal...

A researcher who made a major contribution to our understanding of cancer – and paved the way for several new classes of drug – has died